Beryl A. Koblin, PhD



Member, Research

Research Area

Dr. Koblin’s research is focused on finding ways to prevent HIV infection through testing potential HIV vaccines and other biomedical interventions and developing preventive interventions.  Her research has addressed understanding the changing epidemiology of HIV infection among populations at risk in the United States, critical for designing and targeting interventions for both primary and secondary prevention. Based on the groundwork of these epidemiologic studies, Dr. Koblin has been involved in conducting numerous randomized trials of behavioral and biomedical HIV prevention interventions among multiple populations. In response to the ever growing racial disparities in HIV infection in the US, Dr. Koblin’s has been involved in studies focused on understanding the HIV epidemic and developing and testing HIV prevention interventions among US Blacks.

Contact Information

Phone: +1 (212) 570-3105


Infectious Diseases

Lab Personnel

  • Eddie Bravo
  • Debbie Lucy
  • Geneva Ortiz
  • Jay Loeffel
  • Jermaine McCrossin
  • London Miles
  • Kiwan Stewart
  • Leah Strock
  • DaShawn Usher
  • Tasha Vazquez
  • Hong Van Tieu

Funding Support

  • UM1AI069470 (Hammer/El-Sadr) NIAID/NIH Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit
  • UM1AI068614  (Corey) NIAID/NIH  Protocol Implementation Funds and Scientific Leadership:  HIV Vaccine Trials Network (HVTN)
  • R01HD078595-01 (Koblin) NICHD/NIH Using technology to match young Black MSM to HIV testing options 
  • GSK 201120 (Tieu) GSK/ViiV A Phase IIa Study to Evaluate the Safety, Tolerability and Acceptability of Long Acting Injections of the HIV Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ÉCLAIR) 
  • 1R01DA038108 (Frye) NIDA/NIH  Testing an Intervention to Increase HIV Self-Testing among Young Black MSM 
  • R01MH106380 (Golub) NIMH/NIH  Preparing for Implementation of Sustained Release Antivirals for HIV Prevention